Research News
View articles by month and year
-
Chemo, Hormonal Therapy May Increase Risk of Falling
Research suggests that women who get chemotherapy or hormonal therapy to treat early-stage breast cancer are more likely to fall than women the same age who don't get those treatments.
-
Halavan May Help Treat Metastatic Disease
Women diagnosed with metastatic breast cancer that didn't respond to other treatments who got Halavan lived 2 months longer than women who got supportive care or a standard metastatic cancer treatment.
-
Xeloda Doesn’t Seem to Reduce Recurrence Risk
A new study shows that the risk of recurrence is the same whether or not Xeloda was added to a standard adjuvant chemotherapy regimen for early-stage breast cancer with a high risk of recurrence.
-
Chemo During Pregnancy Doesn’t Harm Baby
New research supports other studies that suggest that chemotherapy during pregnancy doesn't have harmful effects on the baby.
-
Pathologic Complete Response to Treatment Before Surgery Linked to Better Prognosis
Research found that women who got neoadjuvant treatment and had a complete pathologic response were less likely to have the cancer come back compared to women who didn't have a complete pathologic response.
-
Taxotere Better Than Fluorouracil in Chemo Regimen After Surgery for Early-Stage Disease
Chemotherapy that included Taxotere offered slightly better results than a regimen that included 5-FU for women diagnosed with early-stage breast cancer that hadn't spread to the lymph nodes, but Taxotere was more likely to cause serious side effects.
-
Halaven Approved by FDA to Treat Metastatic Breast Cancer
The FDA has approved a new chemotherapy medicine, Halaven (chemical name: eribulin), to treat metastatic breast cancer that already has been treated with other chemotherapy medicines.
-
Experimental Eribulin May Help Treat Various Types of Metastatic Breast Cancer
Research suggests that the experimental medicine eribulin may be a good treatment for various types of metastatic breast cancer that have stopped responding or failed to respond to other treatments.
-
Chemotherapy Before Surgery Can Benefit Advanced-Stage, Triple-Negative Breast Cancer
A small, early study found that 66% of locally-advanced, triple-negative breast cancers treated before surgery with a combination of carboplatin and Taxotere had no living cancer cells in the tumor when it was removed.
-
Old Women More Likely to Have Chemo-Related Cognitive Problems
Being older and having lower cognitive reserve levels may increase the risk of cognitive problems during and after chemotherapy.
